FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on: March 30,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on:March 30,2024

Cancer screening rates decline when patients see doctors later in day

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCompared to patients who see their primary care doctor earlier in the day, cancer screening rates decline

Updated on: March 08,2024

Cancer screening rates decline when patients see doctors later in day

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCompared to patients who see their primary care doctor earlier in the day, cancer screening rates decline

Updated on:March 08,2024

Real-time reconstruction of high-intensity focused ultrasound focal temperature field based on deep learning

by BMEF (BME Frontiers)Invivoreal-time temperature field reconstruction during HIFU treatment using deep learning. Credit: School of Integrated Circuits @ HUST.High-intensity focused ultrasound

Updated on: March 30,2024

Real-time reconstruction of high-intensity focused ultrasound focal temperature field based on deep learning

by BMEF (BME Frontiers)Invivoreal-time temperature field reconstruction during HIFU treatment using deep learning. Credit: School of Integrated Circuits @ HUST.High-intensity focused ultrasound

Updated on:March 30,2024

Study pinpoints what causes relapse after cancer immunotherapy

by Elaine Fuchs,Rockefeller UniversityKiller T cells surround a cancer cell. Credit: NIHHarnessing the body's immune system to fight off cancer, a tactic known as immunotherapy, has tremendo

Updated on: May 25,2024

Study pinpoints what causes relapse after cancer immunotherapy

by Elaine Fuchs,Rockefeller UniversityKiller T cells surround a cancer cell. Credit: NIHHarnessing the body's immune system to fight off cancer, a tactic known as immunotherapy, has tremendo

Updated on:May 25,2024

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food

Updated on: May 21,2024

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food

Updated on:May 21,2024

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on: February 18,2024

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on:February 18,2024

New therapy could help chronic myeloid leukemia patients live drug-free

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageThe latest research from SAHMRI and the University of Adelaide has discovered a potential new therapy for ch

Updated on: January 13,2024

New therapy could help chronic myeloid leukemia patients live drug-free

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageThe latest research from SAHMRI and the University of Adelaide has discovered a potential new therapy for ch

Updated on:January 13,2024

Researchers examine role of fluid flow in ovarian cancer progression

by Virginia TechAfter multiple rounds of fluid shear stress exposure, human cells in the study began to form tumor-like structures known as spheroids (pictured). Spheroids are indicative of aggre

Updated on: June 15,2024

Researchers examine role of fluid flow in ovarian cancer progression

by Virginia TechAfter multiple rounds of fluid shear stress exposure, human cells in the study began to form tumor-like structures known as spheroids (pictured). Spheroids are indicative of aggre

Updated on:June 15,2024

AI could improve diagnostic accuracy of breast dynamic contrast-enhanced magnetic resonance imaging

A deep learning (DL) system could improve the diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of breast tissue for detecting breast cancer, according to a study p

Updated on: January 02,2024

AI could improve diagnostic accuracy of breast dynamic contrast-enhanced magnetic resonance imaging

A deep learning (DL) system could improve the diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of breast tissue for detecting breast cancer, according to a study p

Updated on:January 02,2024

Study gives new insight into how cancer metastasizes to the brain

by The Wistar InstituteIFN signaling is activated in brain metastasis.a–cIFN signaling is activated in both human astrocytes and MDA231-BrM cells by coculture in vitro.N = 2 bio

Updated on: February 20,2024

Study gives new insight into how cancer metastasizes to the brain

by The Wistar InstituteIFN signaling is activated in brain metastasis.a–cIFN signaling is activated in both human astrocytes and MDA231-BrM cells by coculture in vitro.N = 2 bio

Updated on:February 20,2024

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio

Updated on: July 08,2024

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio

Updated on:July 08,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on: January 02,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on:January 02,2024